KEAP1 and type 2 diabetes mellitus: These compounds exhibit promising antidiabetic effects on T2DM via their effects on Keap1/Nrf2 and PPAR-γ signaling pathways in the liver and their inhibitory effects on PTP1B and caspase-3 in liver cells.